本页面由Tiger Trade Technology Pte. Ltd.提供服务

梯瓦制药

30.35
+0.03000.10%
盘后30.520.1706+0.56%16:07 EST
成交量:1,004.73万
成交额:3.05亿
市值:348.20亿
市盈率:49.18
高:30.56
开:30.10
低:29.89
收:30.32
52周最高:30.56
52周最低:12.47
股本:11.47亿
流通股本:11.42亿
量比:1.14
换手率:0.88%
股息:- -
股息率:- -
每股收益(TTM):0.6171
每股收益(LYR):-1.4492
净资产收益率:9.71%
总资产收益率:5.49%
市净率:4.80
市盈率(LYR):-20.94

数据加载中...

2020/08/13

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/06

重要事件披露

8-K - Current report
2020/08/05

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/05

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/05

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/05

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/05

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/05

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/08/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/05

重要事件披露

8-K - Current report
2020/06/19

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/09

重要事件披露

8-K - Current report
2020/05/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/07

重要事件披露

8-K - Current report
2020/02/21

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

重要事件披露

Current report, items 2.02 and 9.01
2020/02/05

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/28

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/25

重要事件披露

Current report, items 1.01, 2.03, and 9.01